Study of risks in superficial radiotherapy with SENSUS SRT-100TM using FMEA and code SECURE MR-FMEA
Keywords:
SOFTWARE DESIGN, QUALITY OF LIFE, RISK, RADIOTHERAPY.Abstract
Introduction: in view of the high incidence of skin cancer, where treatments with ionizing radiation are used, particularly with SENSUS SRT-100TM equipment at Oncology Patient Care Center of Pinar del Río, and the known need to improve the prevention of incidents and accidents related to this practice, an advanced risk-analysis approach, similar to that proposed by the American Association of Physicists in Medicine, was applied using the SECURE MR-FMEA code.
Objective: to develop a risk study for superficial radiotherapy with SENSUS SRT 100TM that identifies the modes and causes of failures associated with the treatment, which allow the use of applications that optimize the safety and quality of the practice.
Methods: the prospective method of failure modes and effect analysis, regarding superficial treatments with SENSUS SRT-100TM through the applications developed by means of the SECURE MR-FMEA code.
Results: the process map was designed with its sub-processes and respective stages by a multidisciplinary team created at Oncology Patient Care Center in Pinar del Río, assisting the global comprehension of the activity and determining the risk profile and specific failure trees (supported by the benefits of the SECURE MR-FMEA program), to create defense measures and developing activities that decreased the risk after the application of the reassessment.
Conclusions: the risk study carried out in superficial radiotherapy made possible to strengthen the safety and quality of the treatments delivered at the Oncology Patient Care Center of Pinar del Río, allowing the future assessmentsDownloads
References
1. Mohan SV, Chang AL. Advanced basal cell carcinoma: epidemiology and therapeutic innovations. CurrDermatol Rep. [Internet] 2014 [Citado 20 de mayo de 2017]; 3(1): [Aprox. 5p.]. Disponible en: https://link.springer.com/article/10.1007/s13671-014-0069-y
2. Anuario estadístico de salud. 2017. Ministerio de Salud Pública, Dirección de registros médicos y estadísticos de salud. La Habana; 2018. Disponible en: http://files.sld.cu/dne/files/2018/04/Anuario-Electronico-Español-2017-ed-2018.pdf
3. Pérez-Bernal L. Epidemiología de las lesiones malignas epiteliales. Revista Universidad Médica Pinareña. [Internet] 2014 [Citado 20 de mayo de 2017]; 11(2): [Aprox. 8p.]. Disponible en: http://galeno.pri.sld.cu/index.php/galeno/article/view/302
4. McGregor S, Minni J, Herold D. Superficial Radiation Therapy for the Treatment of Nonmelanoma Skin Cancers. J ClinAesthet Dedrmatol. [Internet] 2015 [Citado 20 de mayo de 2017]; 8(12): [Aprox. 2p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689506/
5. European Comission. "General guidelines on risk management in external beam radiotherapy". EC report Radiation Protection (RP)-181. ACCIRAD Project; 2015.
6. IAEA. Bonn Call for Action. [Internet] WHO; 2012 [Citado 20 de mayo de 2017]. Disponible en: http://who.int/ionizing_radiation/medical_exposure/bonncallforaction2014.pdf?ua-1
7. Huq MS, et al. The report of Task Group 100 of the AAPM: Application of risk analysis methods to radiation therapy quality management. Med. Phys. [Internet] 2016 [Citado 20 de mayo de 2017]; 43(7): [Aprox. 20p.]. Disponible en: https://www.aapm.org/pubs/reports/RPT_283.pdf
8. Ibanez-Rosello B, Bautista-Ballesteros JA, Baneque J. Failure Mode and effect analysis of skin electronic brachytherapy using Esteya Unit. Journal of Contemporay Brachytherapy. [Internet] 2016 [Citado 20 de mayo de 2017]; 8(6): [Aprox. 6p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241381/
9. Sayler E, Eldredge-Hindy H, Dinome J, et al. Clinical implementation and failure modes and effects analysis of HDR skin brachytherapy using Valencia and Leipzig surface applicators. Brachytherapy[Internet] 2015 [Citado 20 de mayo de 2017]; 14(2): [Aprox. 15p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/25516493
10. Teixeira FC, DE ALMEIDA C, HUQ MS. Failure mode and effects analysis based risk profile assessment for stereotactic radiosurgery programs at three cancer centers in Brazil. Med. Phys. [Internet] 2016[Citado 20 de mayo de 2017]; 43(1): [Aprox. 1p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/26745909
11. Yang F, Cao N, Young L, et al. Validating FMEA output against incident learning data: A study in stereotactic body radiation therapy. Med Phys [Internet] 2015 [Citado 20 de mayo de 2017]; 42(6): [Aprox. 8p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/26127030
12. Torres A, Montes de Oca J. Nuevo algoritmo para análisis de riesgo en radioterapia. Nucleus. [Internet] 2015 [Citado 20 de mayo de 2017]; (58): [Aprox. 6p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-084X2015000200007
13. Torres A, et al. "Evaluación de riesgo de la práctica de radioterapia con rayos X de kilovoltaje". Nucleus [Internet] ene.-jun. 2017 [Citado 20 de mayo de 2017]; (61). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-084X2017000100005
14. Ashley L, Armitage G, Neary M, Hollingsworth G. "A Practical Guide to Failure Mode and Effects Analysis in Health Care: Making the Most of the Team and Its Meetings". The Joint Commission Journal on Quality and Patient Safety. [Internet] 2010 [Citado 20 de mayo de 2017]; 36(8):[Aprox. 8p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/20860241
15. World Health Organization. Radiotherapy Risk Profile-Technical Manual [Internet]. WHO. Geneva; 2008. [Citado 20 de mayo de 2017]. Disponible en: http://www.who.int/patientsafety/activities/technical/radiotherapy_risk_profile.pdf.

Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/